Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Dow
Healthtrust
Cerilliant
Chubb
UBS
Moodys
Daiichi Sankyo
Federal Trade Commission
McKesson

Generated: August 18, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 8,580,830 protect, and when does it expire?


Patent ► Subscribe protects ZUPLENZ and is included in one NDA.

This patent has fourteen patent family members in ten countries.

Summary for Patent: ► Subscribe

Title:Non-mucoadhesive film dosage forms
Abstract: Orally disintegrating film dosage forms for delivering active pharmaceutical agents, methods of formulating the dosage forms to retard absorption through the oral mucosa, and methods of using the dosage forms for the treatment of various medical conditions are provided.
Inventor(s): Leichs; Christian (Alfdorf, DE), Breitenbach; Armin (Leverkusen, DE), Lehrke; Ingo (Cologne, DE), Galfetti; Paolo (Comasco, IT)
Assignee: Labtec GmbH (DE) APR Applied Pharma Research S.A. (CH)
Application Number:12/443,414
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Midatech Pharma Us
ZUPLENZ
ondansetron
FILM;ORAL022524-001Jul 2, 2010RXYesNo► Subscribe► SubscribeY
Midatech Pharma Us
ZUPLENZ
ondansetron
FILM;ORAL022524-002Jul 2, 2010RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: ► Subscribe

PCT Information
PCT FiledOctober 02, 2007PCT Application Number:PCT/EP2007/008579
PCT Publication Date:April 10, 2008PCT Publication Number: WO2008/040534

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia2007304425► Subscribe
BrazilPI0719840► Subscribe
Canada2664986► Subscribe
China101626756► Subscribe
China105168186► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Teva
Chinese Patent Office
US Army
Express Scripts
Farmers Insurance
McKesson
Novartis
Deloitte
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot